Sigyn announces reverse split to support uplist to Nasdaq

Sigyn Logo

Sigyn Therapeutics (OTCQB:SIGY) announced a 1-for-40 reverse split. Sigyn’s common stock is expected to begin trading on a split-adjusted basis on OTCQB when the market opens on Jan. 31.

As a result of the split, Sigyn’s shares will trade under the stock symbol ”SIGYD” for 20 business days and will then revert back to trading under its historic symbol “SIGY” on Feb. 29.

The reverse stock split is intended to increase the market price per share of Sigyn’s common stock to gain compliance with the minimum bid listing requirement of the Nasdaq Capital Market in connection with the company’s pending application for listing.